Studies related to Lung Function and N-Acetylcysteine

Randomised, controlled trial of N-acetylcysteine for treatment of acute exacerbations of chronic obstructive pulmonary disease
Effect None
Trial Design Double blind
Trial Length 1-7 Days
Number of Subjects 50
Sex Both Genders
Age Range 45-64, 65+
Body Types Overweight, Average
Notes for this study:
Supplementation of 600mg NAC in persons undergoing exacerbations of COPD symptoms failed to improve any measured symptom or lung function more than placebo.